Su X - Search Results

1

IE-CycleGAN: improved cycle consistent adversarial network for unpaired PET image enhancement.

Cui J, Luo Y, Chen D, Shi K, Su X, Liu H. Cui J, et al. Among authors: su x. Eur J Nucl Med Mol Imaging. 2024 Nov;51(13):3874-3887. doi: 10.1007/s00259-024-06823-6. Epub 2024 Jul 23. Eur J Nucl Med Mol Imaging. 2024. PMID: 39042332

2

Comparison of [¹⁸F]-OC PET/CT and contrast-enhanced CT/MRI in the detection and evaluation of neuroendocrine neoplasms.

Chen D, Yang S, Chen J, Li T, Liu Y, Zhao X, Zhang T, Xu M, Wang H, Zhao K, Su X. Chen D, et al. Among authors: su x. Eur J Nucl Med Mol Imaging. 2023 Jul;50(8):2420-2431. doi: 10.1007/s00259-023-06200-9. Epub 2023 Mar 27. Eur J Nucl Med Mol Imaging. 2023. PMID: 36971805

3

[No title available]

[No authors listed] [No authors listed] PMID: 38245164

4

The additional value of ¹⁸F-FDG PET/CT imaging in guiding the treatment strategy of non-tuberculous mycobacterial patients.

Chen D, Chen Y, Yang S, Liu K, Wang Z, Zhang T, Wang G, Zhao K, Su X. Chen D, et al. Among authors: su x. Respir Res. 2024 Mar 18;25(1):132. doi: 10.1186/s12931-024-02757-7. Respir Res. 2024. PMID: 38500137 Free PMC article.

5

Development and validation of [18 F]-PSMA-1007 PET-based radiomics model to predict biochemical recurrence-free survival following radical prostatectomy.

Li T, Xu M, Yang S, Wang G, Liu Y, Liu K, Zhao K, Su X. Li T, et al. Among authors: su x. Eur J Nucl Med Mol Imaging. 2024 Jul;51(9):2806-2818. doi: 10.1007/s00259-024-06734-6. Epub 2024 May 1. Eur J Nucl Med Mol Imaging. 2024. PMID: 38691111

6

Correction to: Development and validation of [18 F]-PSMA-1007 PET-based radiomics model to predict biochemical recurrence-free survival following radical prostatectomy.

Li T, Xu M, Yang S, Wang G, Liu Y, Liu K, Zhao K, Su X. Li T, et al. Among authors: su x. Eur J Nucl Med Mol Imaging. 2024 Jul;51(9):2850-2852. doi: 10.1007/s00259-024-06752-4. Eur J Nucl Med Mol Imaging. 2024. PMID: 38787398 No abstract available.

7

Increased uptake of [¹⁸F]MFBG in a patient with potential MEN2 syndrome.

Chen X, Wang G, Yang S, Yan X, Su X, Wang P. Chen X, et al. Among authors: su x. Eur J Nucl Med Mol Imaging. 2024 Dec 11. doi: 10.1007/s00259-024-07005-0. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 39658738 No abstract available.

8

Value of [¹⁸F]AlF-NOTA-FAPI-04 PET/CT for predicting pathological response and survival in patients with locally advanced pancreatic ductal adenocarcinoma receiving neoadjuvant chemotherapy.

Zhang Y, Xu M, Wang Y, Yu F, Chen X, Wang G, Zhao K, Yang H, Su X. Zhang Y, et al. Among authors: su x. Eur J Nucl Med Mol Imaging. 2025 Jan 17. doi: 10.1007/s00259-025-07084-7. Online ahead of print. Eur J Nucl Med Mol Imaging. 2025. PMID: 39820598

9

¹⁸F-FAPI-04 Outperforms ¹⁸F-FDG PET/CT in Clinical Assessments of Patients with Pancreatic Adenocarcinoma.

Li X, Lu N, Lin L, Chen Y, Yang S, Wang H, Liu X, Wu C, Xue X, Su X, Bai X, Liang T. Li X, et al. Among authors: su x. J Nucl Med. 2024 Feb 1;65(2):206-212. doi: 10.2967/jnumed.123.266283. J Nucl Med. 2024. PMID: 38176719 Free PMC article.

10

Characteristics of ¹⁸F-FDG PET/CT in patients with Kimura's disease from China.

Xu M, Zhang Y, Wang G, Lin L, Wu Y, Wang Y, Zhao K, Su X. Xu M, et al. Among authors: su x. BMC Med Imaging. 2024 Oct 8;24(1):269. doi: 10.1186/s12880-024-01446-7. BMC Med Imaging. 2024. PMID: 39379895 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,679 results

Search Page

Filters